Navigation Links
Reaction Monitoring of Processes Under Pressure Using In Situ FTIR
Date:1/19/2009

Compliementary webinar explains the value of in situ mid IR reaction monitoring for promoting a detailed understanding of catalytic and other chemical reactions under pressure.

Columbia, MD (PRWEB) January 19, 2009 -- METTLER TOLEDO invites you to attend a complimentary webinar presented by Dr.Will Kowalchyk Reaction Monitoring of Processes Under Pressure Using In Situ FTIR taking place on April 1, 2009.

Monitoring reactions under pressure poses many challenges. Often, it is impossible to see into the reactor or process because the required pressure necessitates using a metal reactor instead of glass. It is difficult to know when the reaction is complete, much less being able to characterize the reaction kinetics. The accumulation of an unwanted or hazardous species is not uncommon. Taking samples for offline analysis (i.e. HPLC, GC, NMR) can introduce air or moisture into the reaction which can poison catalyst or the samples simply do not reflect the concentrations of the reactive species in their natural environment.

ReactIR™ real-time in situ FTIR can provide a "molecular movie" of the chemical reaction under actual process conditions, including under high pressure. The functional group specificity of FTIR allows the simultaneous monitoring of many chemical species. Our range of probe technologies, specifically designed for pressure chemistry, allows reactions to be monitored to over 350 bar.

This webinar will outline the relevant probe designs and technology for monitoring reactions at elevated pressure. Several pressure chemistry case studies will be presented including reductions (hydrogenation), oxidations, carbonylations, hydroformylations and reactions in supercritical CO2. Schematics and pictures of actual installations will be reviewed showing some very common ways to interface our Comp™ probe technology into a process.

###

Read the full story at http://www.prweb.com/releases/catalytic/reactions/prweb1876654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
2. DNA Predicts Reaction to Drug That Fights Alcohol Dependence
3. Baxter Provides Update on Heparin Reactions
4. Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
5. GM Exec Joins Bio-Reaction Industries Board of Directors
6. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
7. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
8. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
9. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
10. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
11. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reaction Monitoring of Processes Under Pressure Using In Situ FTIR
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree ... products targeting the needs of consumers who are incorporating medical marijuana into their ... Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... , ... October 06, 2017 , ... ... a lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for ... Dana-Farber Cancer Institute. The event is free and open to the public, but ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):